ARTICLE | Company News
Bioheart, Invitrx deal
September 30, 2013 7:00 AM UTC
Invitrx granted Bioheart rights to Invitrx's adipose derived stem cell products for use in all indications in humans and animals. Bioheart intends to use these techniques to advance the development an...